throbber
Pharmaceutical Research Vol 20 No 7 July 2003 © 2003
`
`Research Paper
`
`Hydrotropic Solubilization of
`Paclitaxel Analysis of Chemical
`Structures for Hydrotropic Property
`
`Jaehwi Lee Sang Cheon Lee
`Ghanashyam Acharya1 Chingjer Chang and
`Kinam Park12
`
`Received February 26 2003 accepted March 27 2003
`
`Purpose To identify hydrotropic agents that can increase aqueous
`paclitaxel PTX solubility and to study the chemical structures nec
`essary for hydrotropic properties so that polymeric hydrotropic
`agents can be synthesized
`Methods More than 60 candidate hydrotropic agents or hydro
`to increase the aqueous PTX
`tropes were tested for their ability
`solubility A number
`analogues were synthesized
`of nicotinamide
`showed a favorable hy
`based on the observation
`that nicotinamide
`for PTX were used to
`drotropic property The identified hydrotropes
`examine the structure activity relationship
`Results NADiethylnicotinamide NNDENA was found to be the
`most effective hydrotropic agent for PTX The aqueous PTX solubil
`ity was 39 mgml and 512 mgml at NNDENA concentrations
`of 35
`M and 595 M respectively These values are 56 orders of magnitude
`than the intrinsic solubility of 030 ± 002 Igml N
`greater
`Picolylnicotinamide Nallylnicotinamide and sodium salicylate were
`for PTX Solubility data showed that an
`also excellent hydrotropes
`effective hydrotropic agent should be highly water soluble while
`
`maintaining
`Conclusions
`
`segment
`a hydrophobic
`The present study identified several hydrotropic agents
`effective for increasing aqueous solubility of VD and analyzed the
`for this hydrotropic property This informa
`structural
`requirements
`tion can be used to find other hydrotropic compounds and to synthe
`for VD and other
`size polymeric hydrotropes
`that are effective
`poorly watersoluble drugs
`KEY WORDS hydrotropic agents solubilization poorly water
`soluble drug paclitaxel structure activity relationship
`
`INTRODUCTION
`
`Poor water solubility of many drugs and drug candidates
`causes significant problems in producing formulations with
`sufficiently high bioavailability 13 Paclitaxel PTX
`
`presents a good example of the importance of water solubil
`therapy has been hindered by its low
`ity Its use in cancer
`
`water solubility 4 which has required special formulations
`utilizing ethanol and Cremophore EL polyoxyethylated cas
`tor oil which has significant side effects such as hypersensi
`tivity reactions 5 Testing PTX in preclinical
`tumor model
`systems is also difficult 6 In addition the cosolvent mixture
`
`is diluted in isotonic saline solution before intravenous ad
`ministration and the diluted solution remains stable for only
`several hours 7 For hydrophobic
`drugs with poor water
`solubility including PTX several methods have been used to
`
`of Pharmaceutics and Biomedical Engineering Pur
`1 Departments
`due University West Lafayette Indiana 47907
`2 To whom correspondence
`should be addressed email kpark
`purdueedu
`
`increase their water solubility Poorly watersoluble drugs
`have been formulated into micron or submicronsize particu
`
`late preparations 3 liposomes and micelles 8 and solid
`dispersions 910 Cosolvent systems can increase the drug
`solubility significantly but
`the choices of clinically used sol
`vents are limited to ethylene glycol dimethylsulfoxide NN
`dimethylformamide Cremophore and ethanol 11
`In an attempt
`to find an alternative or supplementary
`method for
`increasing water solubility of poorly soluble
`drugs we have examined the possibility of using hydrotropes
`Hydrotropic agents hydrotropes have been used to increase
`the water solubility of poorly soluble drugs and in many in
`stances the water solubility has increased by orders of mag
`nitude 12 Hydrotropy is a collective molecular phenom
`enon describing an increase in the aqueous
`solubility of a
`poorly soluble compound by addition of a relatively large
`
`amount of a second solute ie a hydrotrope 1 Each hy
`
`is effective in increasing the water solubility
`drotropic agent
`hydrophobic drugs and no universal hydrotropic
`of selected
`agent has been found to be effective with all hydrophobic
`drugs Thus finding the right hydrotropic agents for a par
`drug requires the screening of a large
`ticular hydrophobic
`number of candidate hydrotropes In this study we examined
`various candidate agents for their abilities to solubilize PTX
`the structures of effective agents can be used for iden
`so that
`tification of other hydrotropic agents and for synthesis of hy
`drotropic polymers
`
`MATERIALS AND METHODS
`
`Materials
`
`PTX was obtained from Samyang Genex Corp Taejeon
`South Korea 6Hydroxynicotinic acid 11carbonyl
`diimidazole CDI diethylamine 3picolylamine nicotinoyl
`chloride hydrochloride allylamine acetic anhydride pyri
`dine and triethylamine were purchased from Aldrich Chemi
`cal Company Milwaukee WI and used without further pu
`chloride was dried and distilled over
`rification Methylene
`calcium hydride Tetrahydrofuran THF was distilled from
`sodium benzophenone before use n Hexane diethyl ether
`chloroform and methanol were of reagent grade All other
`chemicals were purchased from Fisher Scientific Pittsburgh
`PA Freshly prepared distilled water was used throughout
`
`Synthesis and Characterization of Nicotinatnide Analogues
`
`Instrumental Analysis
`111 and 13C NMR spectra were obtained using a Bruker
`ARX300 spectrometer at 300 MHz and 75 MHz respectively
`Elemental analysis was performed on a Perkin Elmer Series
`II CHNSO Analyzer 2400 UVVIS spectra were obtained by
`a Beckman DU® 640 spectrophotometer
`ion
`Electrospray
`ization mass spectrometry ESIMS assay was done using a
`FinniganMAT LCQ ThermoFinnigan Corp San Jose CA
`The electrospray needle voltage was set at 45 kV the heated
`to 10 V and the capillary tempera
`capillary voltage was set
`ture to 225°C Typical background source pressure was 12 x
`105 torr The sample flow rate was approximately 10 pimin
`Nitrogen gas was used for drying The LCQ was scanned to
`2000 amu for these experiments
`
`072487411030700102210
`
`© 2003 Plenum Publishing Corporation
`
`1022
`
`Abraxis EX2042
`Actavis LLC v Abraxis Bioscience LLC
`1PR201701101 1PR201701103 1PR201701104
`
`

`

`Hydrotropic Solubilization of Paclitaxel
`
`1023
`
`NPicolylnicotinamide
`
`To a solution of 3picolylamine 01 mol and pyridine
`02 mol in dry methylene chloride 600 ml was added nico
`tinoyl chloride hydrochloride 01 mol at 0°C The reaction
`mixture was stirred at room temperature for 24 h under ni
`trogen After 24 h the solvent was removed under
`reduced
`pressure and the crude product was dissolved in water neu
`tralized with sodium bicarbonate
`and extracted with chloro
`form 3 x 200 nil The solution was dried over anhydrous
`magnesium sulfate The solvent was removed at reduced pres
`sure and the product was isolated by column chromatogra
`phy on a silica gel using THFnhexane Yield was 80 mp
`105107°C XmaxTHF 256 nm 1H NMR DMSOd6 8 452
`d T = 58 Hz 2H 734 dd T = 48 77 Hz 1H 749 dd
`T = 48 81 Hz 1H 772775 m 1H 820823 m 1H
`846 dd T = 10 48 Hz 1H 858 d T = 24 Hz 1H 870
`dd T = 10 48 Hz 1H 906 d T = 20 Hz 1H 929 t T
`= 58 Hz 1H 13C NMR DMSOd6 8 404 1234 1296
`1347 1350 1351 1482 1483 1485 1489 1519 1649 ESI
`MS mz 214 14+H1 analysis calculated for Ci2HN30 C
`6759 H 520 N 1971 Found C 6773 H 510 N 1951
`
`NAllylnicotinamide
`
`To a stirred solution of allylamine 0168 mol in dry
`methylene chloride 500 ml nicotinoyl chloride hydrochlo
`ride 0112 mol and triethylamine 0225 mol were added at
`0°C The reaction mixture was stirred at room temperature
`for 24 h under nitrogen After 24 h the solvent was removed
`reduced pressure The brown liquid was dissolved in
`under
`distilled water and neutralized with sodium bicarbonate
`fol
`lowed by extraction with chloroform 3 x 200 nil The solvent
`was removed at reduced pressure and the crude product was
`column chromatographed with THFnhexane on a silica gel
`to produce a light yellow liquid Yield was 85 XmaxTHF
`260 nm 1H NMR DMSOd6 8 389394 m 2H 505520
`m 2H 582594 m 1H 747 dd T = 50 83 Hz 1H
`820 m 1H 868 dd T = 17 50 Hz 1H 887 t T = 56
`Hz 1H 904 d T = 17 Hz 1H 13C NMR DMSOd6 8
`415 1153 1233 1299 1349 1350 1485 1517 1646 ESI
`MS mz 163 M+Hr analysis calculated for C9110N20 C
`6665 H 621 N 1727 Found C 6653 H 607 N 1697
`
`6HydroxyNNDiethylnicotinamide
`
`To a stirred suspension of 6hydroxynicotinic acid 0108
`mol in THF 600 ml was added CDI 0108 mol in one
`portion The reaction mixture was stirred at reflux under ni
`trogen After 24 h diethylamine 0216 mol was added drop
`wise to the stirred suspension of N6hydroxynicotiny1
`imidazole in THF at reflux The reaction was further main
`tained for 24 h under nitrogen After cooling of the reaction
`mixture to room temperature 1N sodium hydroxide solution
`120 ml was added THF was evaporated
`and the aqueous
`solution of the crude product was washed with diethyl ether
`5 x 200 m1 The aqueous solution was then neutralized with
`1 N hydrochloric
`acid to pH 7 and extracted with chloroform
`3 x 200 m1 The solution was dried over anhydrous magne
`sium sulfate The solvent was removed at reduced pressure
`and the product was isolated by column chromatography
`on a
`Yield was 65 mp 113
`silica gel using THFnhexane
`115°C XmaxTHF 253 nm 1H NMR DMSOd6 8 109 t T
`
`= 72 Hz 6H 332 q T = 72 Hz 4H 634 d I = 91 Hz
`1H 745 dd I = 24 91 Hz 1H 750 d T = 24 Hz 1H
`13C NMR DMSOd6 8 133 410 1144 1193 1355 1397
`1619 1668 ESIMS mz 195 14+Hr analysis calculated
`for Ci0HN202 C 6184 H 727 N 1442 Found C 6173
`H 716 N 1447
`
`2HydroxyNNDiethylnicotinamide
`
`To a stirred suspension of 2hydroxynicotinic acid 0216
`in THF 700 ml was added CDI 0216 mol in one
`mol
`portion The reaction mixture was stirred at reflux under ni
`trogen After 24 h diethylamine 0323 mol was added drop
`wise to the stirred suspension of N2hydroxynicotiny1
`imidazole in THF at reflux The reaction was maintained for
`24 h under nitrogen After cooling of the reaction mixture to
`room temperature the solution was concentrated under re
`duced pressure The pale yellow precipitate was
`filtered
`washed with diethyl ether and dried in vacuo Yield was 70
`mp 9092°C XmaxTHF 313 nm 1H NMR DMSOd6 8
`100 t T = 72 Hz 3H 107 t T = 72 Hz 3H 312 q T =
`72 Hz 2H 335 q T = 72 Hz 2H 620 m 1H 738 dd
`T = 24 69 Hz 1H 741 dd T = 24 69 Hz 1H 13C NMR
`DMSOd6 8 128 141 384 422 1046 1293 1361 1384
`1592 1662 ESIMS mz 195 14+H1 analysis calculated
`for Ci0H4N202 C 6184 H 727 N 1442 Found C 6214
`H 718 N 1442
`
`NPicolylacetamide
`
`To a stirred solution of acetic anhydride 0069 mol in
`THF 50 ml a solution of 3picolylamine 0046 mol in THF
`20 ml was added dropwise at room temperature The reac
`tion mixture was stirred for 5 h under nitrogen After 5 h an
`excess of water was added and the aqueous solution was
`neutralized with 1 N sodium hydroxide The solvent was re
`moved at reduced pressure and the product was isolated by
`on a silica gel using THFnhexane
`column chromatography
`Yield was 85 XmaxTHF 257 nm 1H NMR CDC13 8 190
`s 3H 429 d T = 57 Hz 2H 716 dd T = 48 82 Hz
`1H 739 s 1H 754 m 1H 834 dd T = 14 48 Hz 1H
`835 d T = 14 1H 13C NMR CDC13 8 227 407 1234
`1342 1355 1481 1486 1704 ESIMS mz 151 14+Hr
`analysis calculated for C8fli0N20 C 6398 H 671 N 1865
`Found C 6385 H 661 N 1854
`
`NMR Measurement
`
`The 1H NMR spectra of NNDENA in D20 in the con
`centration range of 00025 to 136 M were obtained The ratios
`protons to the chemical
`shift of HDO protons 463 ppm were monitored with in
`creasing NNDENA concentrations
`
`of chemical shifts of nicotinamide
`
`Solubility Study
`
`Excess PTX was added to screw capped vials containing
`a fixed volume of the hydrotrope solution This mixture was
`for 24 h at 37°C An
`bar
`stirred using a magnetic stirring
`aliquot of the sample was collected
`and within 5 s it was
`filtered through a 02pm nylon membrane This immediate
`process prevented any possible formation of PTX
`
`filtering
`
`

`

`in the Presence of Various Hydrotropic Agents at 37°C
`used Mb
`
`PTX solubility mgml
`
`Concentration
`
`1024
`
`Table I Paclitaxel Solubilities
`
`Hydrotropic agent
`
`None PTX solubility in pure water
`NNDiethylnicotinamide
`NPicolylnicotinamide
`
`NAllylnicotinamide
`Sodium salicylate
`
`2Methacryloyloxyethyl phosphorylcholine
`
`Resorcinol
`
`N NDimethylnicotinamide
`NMethylnicotinamide
`
`Butylurea
`
`Pyrogallol
`
`NPicolylacetamide
`Procaine HC1
`Nicotinamide
`
`Pyridine
`
`3Picolylamine
`Sodium ibuprofen
`Sodium xylenesulfonate
`Ethyl carbamate
`
`6HydroxyNNdiethylnicotinamide
`Sodium ptoluenesulfonate
`
`Pyridoxal hydrochloride
`
`35
`
`35
`
`35
`
`35
`29
`35
`
`35
`
`35
`
`35
`
`35
`
`35
`25
`35
`35
`
`35
`15
`25
`
`00003
`39071
`
`29435
`
`14184
`
`5542
`
`3199
`
`2009
`
`1771
`
`1344
`
`1341
`
`1282
`
`1084
`
`0720
`
`0694
`0658
`
`0552
`0500
`
`0481
`
`0300
`0241
`
`0220
`
`0216
`
`Lee et al
`
`Standard deviation
`
`00000
`
`0600
`
`1205
`
`0385
`
`0514
`
`0037
`
`0012
`
`0026
`
`0006
`
`0071
`
`0008
`
`0003
`
`0005
`
`0031
`0080
`
`0063
`0070
`
`0080
`
`0028
`0004
`
`0002
`
`0008
`
`1Methy12pyrrolidone
`Sodium benzoate
`
`2Pyrrolidone
`
`Ethylurea
`
`N NDimethylacetamide
`NMethylacetamide
`Isoniazid
`
`35
`20
`25
`25
`35
`20
`35
`
`35
`
`35
`
`35
`10
`
`0071
`
`0050
`
`0038
`
`0030
`
`0015
`
`0012
`
`0009
`
`0002
`
`0006
`
`0002
`
`0003
`
`0002
`
`0001
`
`0002
`
`Mean ± SD n = 3 except for PTX solubility in pure water where n = 10
`less than 35 M represent
`the maximum solubilities of the hydrotropic agent
`b The concentrations
`b The aqueous PTX solubility is 030 ± 002 rigmi
`
`particles as a result of the temperature decrease
`The filtrate was diluted with acetonitrile 11 and the con
`centration of PTX was determined
`by an isocratic reverse
`phase HPLC Agilent 1100 series Agilent Technologies Wil
`mington DE using a Symmetry column Waters Corp
`
`to ambient
`
`Milford MA at 25°C The mobile phase consisted of aceto
`nitrilewater 4555 vv with a flow rate of 10 mlmin A
`diode array detector was set at 227 nm and linked to Chem
`Station software for data analysis The PTX concentrations in
`the samples were obtained from a calibration curve
`
`184
`
`H2 411104111
`
`182 I
`
`H6
`
`0
`
`0 0
`
`o
`
`o
`
`180 1
`
`165 1
`
`V Ir
`
`160 H5
`
`V V V
`
`Zvvv
`
`1
`
`0
`
`3
`2
`NNDiethylnicotinamide Log M
`Fig 2 The ratio of chemical shifts of nicotinamide
`protons to the
`chemical shift of HDO protons in D20 as a function of the concen
`115 and 116 indicate
`tration of NNdiethylnicotinamide
`the proton
`position of the nicotinamide
`ring of NNdiethylnico
`tinamide
`
`fChemicalShift
`
`Ratioso
`
`600
`
`500
`
`cr
`
`> 400
`
`2 300
`0
`co
`ITI 200
`
`00009
`
`E
`
`00006
`
`2 00003
`
`NNDiethylnicolinamide
`
`Log M
`
`T 100
`0
`0s
`
`0
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`0
`NNDiethylnicotinamide M
`Fig 1 Paclitaxel solubility as a function of the molar concentration
`The solubility of paclitaxel at 595 M of
`of NNdiethylnicotinamide
`NNdiethylnicotinamide is 5126 mgml The inserted plot shows the
`of NN
`paclitaxel solubility as a function of the log concentration
`
`diethylnicotinamide
`
`

`

`Hydrotropic Solubilization of Paclitaxel
`
`1025
`
`0
`CH380
`CNHCHCHO
`
`0
`
`U113
`
`0
`
`OH
`
`HO
`
`0
`OH
`II CH4
`
`0
`
`H
`
`C=0
`
`CH3
`
`=0
`
`Fig 3 Chemical structure of paclitaxel
`
`RESULTS AND DISCUSSION
`
`Paclitaxel Solubility by Hydrotropes
`
`lists
`
`and very low
`Because of its noted therapeutic potential
`water solubility PTX was
`chosen
`to examine hydrotropic
`properties of various agents in this study The exact mecha
`nisms involved in solubilization of PTX and other poorly
`are not clearly under
`soluble drugs by hydrotropic agents
`the structural
`stood so it
`is difficult
`to predict
`requirements of
`hydrotropes suitable for solubilizing PTX For this reason a
`large number of candidate agents were screened Table I
`the agents tested and the corresponding water solubilities of
`PTX measured in the presence of those agents Our prelimi
`that even good hydrotropes required a
`nary study suggested
`hydrotropic concentration of approximately 3 M For this rea
`son a concentration of 35 M was used for all agents to com
`the same condition
`pare their hydrotropic properties under
`The concentrations
`of some agents
`listed in Table I are
`smaller than 35 M because of their limited solubility Table I
`clearly identifies a number of hydrotropic agents effective for
`increasing the water solubility of PTX
`The aqueous solubility of PTX at 37°C was determined
`to be 030 ± 002 pLgml Thus a PTX concentration
`of 39
`mgml by NNdiethylnicotinamide NNDENA in Table I
`indicates more than 100000 fold increase in aqueous solu
`bility Equally effective was Npicolylnicotinamide N
`Allylnicotinamide sodium salicylate and 2methacryloyloxy
`increased the PTX solubility by four
`ethyl phosphorylcholine
`
`that
`
`orders of magnitude Other hydrotropes
`resulted in an
`aqueous PTX solubility more than 1 mgml were resorcinol
`NNdimethylnicotinamide Nmethylnicotinamide
`butyl
`urea pyrogallol and Npicolylacetamide The PTX solubility
`of 03 mgml by ethyl carbamate appears to be much smaller
`than that by NNDENA but still
`represents a 1000 fold in
`crease
`Another 35 agents not listed in Table I showed paclitaxel
`of 0005 mgml or 5 pigm1 or less They are
`solubilities
`in the descending order of solubilizing effect nipecotamide
`
`diamino2hydroxypropaneNNN Ntetramethylacetate
`
`35 M citric acid 20 M sodium gentisate 10 M N
`isopropylacrylamide 15 M methylurea 35 M 13
`30 M thiourea 25 M 1methylnicotinamide iodide 10
`M ticyclodextrin 015 M sodium thiocyanate 86 M
`urea 60 M caffeine 01 M glyceryl
`triacetate 02 M
`glycerin 35 M adenosine 0005 M ycyclodextrin 017
`M I3cyclodextrin 002 M diisopropylnicotinamide 005
`M pyridine3sulfonic acid 10 M o benzoic acid sulfimide
`001 M 26pyridinedicarboxamide 00025 M 34
`pyridinedicarboxamide 0025 M 4aminosalicylic
`0005 M Ltryptophan 005 M salicylaldoxime 01 M
`sucrose 20 M Llysine 20 M 4aminobenzoic
`salt 25 M Dsorbitol 30 M sodium Lascorbatc 30 M
`sodium propionate 35 M sodium acetate 40 M 2hy
`02 M 2hydroxyN
`00035 M and 6hydroxyN
`picolylnicotinamide 008 M
`Hydrotropic Property of NNDENA
`The hydrotropic property of NNDENA was examined in
`more detail Figure 1 shows the paclitaxel solubility as a func
`tion of the NNDENA concentration NNDENA at 595 M
`increased the PTX concentration to 512 mgml equivalent to
`06 M because the molecular weight of PTX is 854 gmol and
`this corresponds to 10 NNDENA molecules per paclitaxel
`molecule dissolved At the concentration
`of hydrotropes used
`in Table I however more than 100 hydrotropic agents
`are
`necessary for effective solubilization of PTX The inserted
`plot in Fig 1 shows the solubility increase of PTX as a func
`of NNDENA in the range of
`the log concentration
`tion of
`
`acid
`
`acid sodium
`
`droxyNNdiethylnicotinamide
`picolylnicotinamide
`
`Structure
`
`0
`
`CN
`
`CH2CH3
`
`L
`
`ai2uri3
`
`j
`
`N1
`
`CH2CH3
`
`CH2 CH3
`
`0 I
`
`I
`
`cnc
`
`CH2CH3
`
`CH2CH3
`
`Hydrotropic agent
`
`NNDiethylnicotinamide
`
`6HydroxyNNdiethylnicotinamide
`
`2HydroxyNNdiethylnicotinarnide
`
`Table II
`
`Conc used
`
`M
`
`PTX solubility
`mgml
`
`35
`
`20
`
`02
`
`20
`
`02
`
`3907
`
`098
`
`0001
`
`024
`
`000
`
`The maximum solubility of
`
`the hydrotropic agent
`
`

`

`1026
`
`Lee et al
`
`00028 to 05 M The water solubility of PTX begins to in
`crease at 011 M of NNDENA although the increase is small
`compared to higher concentrations of NNDENA
`Because the dissolution of PTX in NNDENA is expected
`through association of NNDENA molecules self
`to occur
`of NNDENA molecules was examined
`association
`using
`NMR Figure 2 shows
`the NNDENA concentration depen
`dence of the ratio of chemical shifts of nicotinamide protons
`to the chemical shift of HDO protons in D20 As the con
`centration of NNDENA increased to about 01 M the ratios
`the nicotinamide
`of chemical shifts of all protons of
`started to decrease The data indicate that NNDENA self
`via the vertical plane to plane interaction
`the
`associates
`of
`aromatic rings The crossover point in Fig 2 can be described
`as the minimum hydrotropic concentration MHC which is
`of selfaggregate formation The
`the threshold concentration
`MHC value of NNDENA in the aqueous media was esti
`mated to be 012 M Interestingly this MHC value is almost
`of 011 M where NNDENA
`the same as the concentration
`begins to exhibit the solubilizing ability for PTX in aqueous
`solutions
`
`ring
`
`Structural Analysis of Hydrotropic Property for PTX
`To gain insights into the structural
`requirements neces
`sary for hydrotropy chemical structures of various agents
`listed in Table I were analyzed for their ability to increase
`aqueous PTX solubility The structure of PTX is shown in Fig
`3 A few common features of good hydrotropes for PTX were
`identified
`
`High Water Solubility of Hydrotropic Agents
`The main criterion for effective hydrotropy is high water
`the water solubility is
`If
`solubility of the hydrotropic agent
`
`low eg less than 2 M the hydrotropic property is not ob
`served to be significant At 20 M PTX solubility was higher
`in NNDENA than in 6hydroxyNNdiethylnicotinamide
`The PTX solubility in NNDENA was greatly increased with
`the NNDENA concentration 2HydroxyNN
`increasing
`diethylnicotinamide with the maximum water solubility of
`only 02 M did not have any PTXsolubilizing effect The
`following example shows the importance of water solubility of
`aqueous PTX solubility
`on increasing
`
`hydrotropic agents
`Table II
`
`Table III
`
`Hydrotropic agent
`
`Conc
`
`used M PTX solubility
`
`mgml
`
`Sodium salicylate
`
`35
`
`554
`
`Pyrogallol 123
`trihydroxybenzene
`
`35
`
`128
`
`Nicotinamide
`
`3Picolylamine
`
`Nipecotamide
`
`NNDimethylacetamide
`
`NIsopropylacrylamide
`
`35
`
`35
`
`35
`
`35
`
`15
`
`069
`
`055
`
`0005
`
`0015
`
`0004
`
`Structure
`
`OH
`
`OH
`
`CN H2
`
`11
`
`0
`
`0
`
`CH a NG GH3
`
`CH3
`
`CH3
`H2C=HCCNHC11
`
`CH3
`
`13Diamino2hydoxypropane
`NNN Ntetramethylacetate
`
`0004
`
`HO
`
`The maximum solubility of
`
`the hydrotropic agent
`
``COOC H3
`0000 H
`N
`
`3
`
`H 3
`
`

`

`Hydrotropic Solubilization of Paclitaxel
`
`1027
`
`Structure
`
`cH2cH
`
`CN
`
`CH2CH3
`
`CH3
`
`CH3
`
`H
`
`CH3
`
`0 I
`
`I
`
`0
`
`II
`
`0 1
`
`1
`
`H2
`
`I
`
`N H2
`
`I
`
`IC
`
`CH3
`
`0
`
`Table IV
`
`Hydrotropic agent
`Conc used
`
`Conc used
`
`M
`
`FIX solubility
`mgml
`
`NNDiethylnicotinamide
`
`NNDimethylnicotinamide
`
`NMethylnicotinamide
`
`Nicotinamide
`
`35
`
`35
`
`35
`
`35
`
`3907
`
`177
`
`134
`
`069
`
`1Methylnicotinamide iodide
`
`10
`
`0003
`
`NNDiisopropylnicotinamide
`
`005
`
`0001
`
`The maximum solubility of
`
`the hydrotropic agent
`
`Hydrotropic agent
`Conc used
`
`Table V
`
`FIX solubility
`mgml
`
`Structure
`
`Sodium xylenesulfonate 25 Mr
`Sodium ptoluenesulfonate 25 Mr
`
`1Methy12pyrrolidone 35 M
`2Pyrrolidone 35 M
`
`NMethylnicotinamide 35 M
`Nicotinamide 35 M
`
`048
`
`022
`
`007
`
`004
`
`134
`
`069
`
`The maximum solubility of
`
`the hydrotropic agent
`
`CH3
`
`SO3N a
`
`SO3Na
`
`N
`
`1
`
`CH3
`
`H
`
`0
`
`IICN
`
`r t3
`
`ço
`
`CN H2
`
`

`

`1028
`
`Lee et al
`
`Table VI
`
`Conc
`used
`
`PTX
`
`M mgml
`
`solubility
`
`Hydrotropic agent
`
`Resorcinol
`
`13dihydroxybenzene
`
`35
`
`2009
`
`Pyrogallol
`
`123trihydroxybenzene
`
`35
`
`1282
`
`Structure
`
`OH
`
`OH
`
`OH
`
`OH
`
`The agents that did not show any appreciable hydrotro
`have low water solubilities as expected Ex
`triacetate 02 M caffeine 01 M sali
`pic properties
`cylaldoxime 01 M 34pyridinedicarboxamide 0025 M
`amples are glyceryl
`o benzoic acid sulfimide 001 M 4aminosalicylic acid 0005
`M adenosine 0005 M and 26pyridinedicarboxamide
`00025 M Those agents have low water solubility and thus
`
`showed almost no hydrotropic effect
`
`High Hydrophobicity of Hydrotropic Agents
`For those agents having high water solubilities the hy
`the
`drotropic property increases as
`the hydrophobicity of
`molecule increases Poorly soluble organic drugs are all hy
`drophobic ie nonpolar and do not interact with water mol
`ecules through hydrogen bonding Thus the presence or in
`drug molecules in water known as
`sertion of hydrophobic
`hydrophobic hydration causes a direct perturbation of water
`ie an alteration in the hydrogen bonding state of water mol
`ecules Water structure formers such as sucrose and sorbitol
`of poorly soluble drugs whereas water
`increase the solu
`structure disruptors such as nicotinamide
`bility by destroying clusters of associated water molecules and
`releasing water of solvation 13 Thus effective hydrotropic
`agents are expected to destabilize water structure and at the
`same time interact with poorly soluble drugs Hydrotropic
`
`inhibit dissolution
`
`component are not
`agents lacking a significant hydrophobic
`effective at all The following examples show the importance
`of hydrophobic groups in promoting hydrotropic properties
`
`Importance of Pyridine and Benzene Rings
`
`Almost all highly effective hydrotropic agents listed in
`Table I have either a pyridine or a benzene ring in their
`structures Molecules without such rings in their structures
`were not as effective as those containing the ring structures
`As shown in Table III nicotinamide
`and 3picolylamine dis
`the same hydrotropic property while nipecot
`played about
`
`amide which has a saturated ring structure is less than 1
`
`effective as nicotinamide Other agents without pyridine or
`benzene ring that had very small hydrotropic effect are urea
`and its alky derivatives methyl ethyl and butylurea glyc
`erin thiourea Nisopropylacrylamide Nmethylacetamide
`and 13
`NNdimethylacetamide
`sodium thiocyanate
`diamino2hydroxypropaneNNNNtetramethylacetate
`
`Maximum Hydrophobicity without Losing Water Solubility
`
`The hydrotropic properties
`of nicotinamide
`derivatives
`of mol
`show a positive correlation with the hydrophobicity
`ecules as long as water solubility is not lost As shown in Table
`IV NNDENA showed more than a 20 times higher hydro
`at the same
`tropic property than NNdimethylnicotinamide
`in turn was more
`concentration NNDimethylnicotinamide
`than Nmethylnicotinamide and Nmethylnic
`effective
`otinamide was twice as effective as nicotinamide 1Methyl
`iodide was too hydrophilic to be hydrotropic
`nicotinamide
`The poor hydrotropic property of NNdiisopropylnicotin
`amide results from its poor water solubility which is only
`005 M
`
`Increase in the Hydrotropic Property by a Factor of Two
`with a Methyl Group on the Ring
`
`At the same concentration
`
`sodium xylenesulfonate was
`
`more hydrotropic than sodium ptoluenesulfonate Table V
`A similar trend was seen with 1methyl2pyrrolidone and
`2pyrrolidone In both examples the presence of one methyl
`group increased the hydrotropic property of the molecule by
`
`Table VII
`
`Hydrotropic agent
`
`Conc usedM
`
`PTX solubility
`mgm1
`
`Structure
`
`NPicolylnicotinamide
`
`35
`
`2944
`
`NAllylnicotinamide
`
`NNDimethylnicotinamide
`
`35
`
`35
`
`1418
`
`177
`
`NH
`
`ifCH3CN
`
`UF13
`
`

`

`Hydrotropic Solubilization of Paclitaxel
`
`1029
`
`a factor of 2 The same result was observed for Nmethylni
`cotinamide and nicotinamide
`
`Decrease
`
`in Hydrotropic Property with a Hydroxyl Group
`The hydrophilicity of a molecule can be increased by
`attaching hydroxyl groups to the molecule Increase in hydro
`philicity comes with a reduction in the hydrotropic properties
`of the molecule For example pyrogallol which is more hy
`drophilic than resorcinol
`has lower hydrotropic property
`Table VI
`
`More Effective Hydrotropic Property by One Long
`Hydrophobic Chain Than by Two Shorter
`Hydrophobic Chains
`
`As shown in Table VII the high hydrotropic properties
`of Npicolylnicotinamide
`and Nallylnicotinamide
`suggest
`that one longer carbon chain is better than two shorter carbon
`chains eg one allyl group vs two methyl groups A signifi
`increase in PTX solubility by Npicolylnicotinamide may
`be partly related to the presence
`of another pyridine ring that
`
`cant
`
`Hydrotropic agent
`
`Conc used
`
`M
`
`PTX solubility
`mgm1
`
`Structure
`
`Table VIII
`
`Sodium salicylate
`
`35
`
`554
`
`2Methacryloyloxyethyl
`
`phosphorylcholine
`
`29
`
`320
`
`I13
`H2C=
`
`00 H 2CH2ONC H2CH2N CI199
`
`HCI
`
`I 0
`
`I
`
`C0C H2C H2NC2H52
`
`0
`
`H3C
`
`ON a
`
`Procaine HC1
`
`25
`
`072
`
`H2N
`
`Sodium ibuprofen
`
`15
`
`050
`
`Sodium xylenesulfonate
`
`25
`
`048
`
`Sodium ptoluenesulfonate
`
`25
`
`022
`
`Pyridoxal hydrochloride
`
`25
`
`022
`
`HO H2C
`
`Sodium benzoate
`
`005
`
`Isoniazid
`
`10
`
`001
`
`The maximum solubility of
`
`the hydrotropic agent
`
`SO3N a
`
`CH3
`
`OH
`
`HCI
`
`CHO
`COONa
`
`rN
`
`CON HN H2
`
`

`

`1030
`
`Lee et al
`
`is shown to be essential for hydrotropic property as discussed
`above
`
`Hydrophobic
`and Solute
`
`Interaction between Hydrotropic Agent
`
`Aliphatic derivatives of urea were studied for their ef
`fects on increasing the water solubility of PTX Butylurea
`shows
`the highest solubilizing effect among the analogues
`studied which suggests that as the hydrophobicity
`decreases
`the hydrotropic property also decreases Urea is known to
`break up the hydrogen bonded water molecule clusters sur
`solute molecules The poor hydrotropic
`rounding nonpolar
`property of urea suggests that disruption of water structure
`alone without substantial
`interaction with solute is not
`
`enough for effective hydrotropy
`
`Separation of Hydrophilic and Hydrophobic Domains
`A good hydrotropic agent appears to have hydrophilic
`domains on the same molecule Examples
`and hydrophobic
`are shown in Table VIII This is reasonable because hydro
`tropic agents are expected to have nonbonded hydrophobic
`solute molecules while main
`interactions with hydrophobic
`taining hydrophilic property for high water solubility It
`interesting to note that sodium salicylate is highly effective in
`dissolving PTX The carboxyl
`and hydroxyl groups are lo
`on the same side of
`the molecule resulting in clear
`cated
`separation of the hydrophilic domain from the hydrophobic
`domain The same may be true with 2methacryloyloxyethyl
`phosphorylcholine
`
`29 M ProcaineHC1 25 M sodium
`ibuprofen 15 M sodium xylenesulfonate 25 M and so
`p toluenesul
`dium
`fonate 25 M show easily identifiable separation of hydro
`
`is
`
`philic and hydrophobic parts
`
`Polymeric Hydrotropic Agents
`
`Although hydrotropic agents can increase the water solu
`bility of poorly soluble drugs by several orders of magnitude
`they have not been explored extensively in the pharmaceutics
`field The main reason for this may be the concern that
`the
`use of low molecular weight hydrotropic agents at high con
`in undesirable side effects including
`centrations may result
`however may be
`toxicity and cell damages This concern
`alleviated by preparing polymeric forms of hydrotropes For
`this reason we synthesized polymers of hydrotropic agents
`effective for PTX and hydrotropic polymers were as effective
`in increasing the wa
`as the low molecular weight counterpart
`ter solubility of PTX For example a polymeric form of N
`
`their hydrotropic properties
`
`picolylnicotinamide maintains
`14 Table I suggests several candidate hydrotropic agents
`into polymers NNDENA N
`that can be synthesized
`and sodium salicy
`picolylnicotinamide Nallylnicotinamide
`late appear to be good candidates for making polymeric hy
`drotropic agents for PTX
`ACKNOWLEDGMENTS
`
`This study was supported in part by National Institute of
`Health through grant GM 65284 Samyang Corporation and
`NSF IndustryUniversity Center for Pharmaceutical Process
`ing Research
`
`REFERENCES
`1 S H Yalkowsky Solubility and Solubilization in Aqueous Media
`American Chemical Society Washington DC 1999
`2 R LObenberg G L Amidon and M Vierira Solubility as a
`to drug absorption In J B Dressman and H Len
`limiting factor
`nernas eds Oral Drug Absorption Prediction and Assessment
`Marcel Dekker New York 2000 pp 137153
`3 R H Muller and B BOhm Nanosuspensions
`In R H Muller S
`Benita and B BOhm eds Emulsions and Nanosuspensions for
`the Formulation of Poorly Soluble Drugs Medpharm Scientific
`Publishers Stuttgart 1998 pp 149174
`4 B R Goldspiel Clinical overview of the taxanes Pharmaco
`therapy 17110S 125S 1997
`5 R Paradis and M Page New active paclitaxel amino acids de
`rivatives with improved water solubility Anticancer Res 182711
`2716 1998
`6 S Y Leung J Jackson H Miyake H Burt and M E Gleave
`phosphorylates Bc12 and induces
`Polymeric micellar paclitaxel
`LNCaP prostate
`regression of androgen independent
`apoptotic
`tumors Prostate 44156163 2000
`7 A G Floyd and S MM Injectable emulsions and suspensions In
`H A Lieberman M M Rieger and G S Banker eds Phar
`maceutical Dosage Forms Disperse Systems Vol 2 Marcel Dek
`ker New York 1998 pp 261318
`8 H AlkanOnyuksel S Ramakrishnan H B Chai and J M
`Pezzuto A mixed micellar formulation suitable for the parenteral
`administration of taxol Pharm Res 11206212 1994
`9 J L Ford The current status of solid dispersions Pharm Acta
`Hely 616988 1986
`10 A T M Serajuddin Solid dispersion of poorly watersoluble
`drugs Early promises subsequent problems and recent break
`throughs J Pharm Sci 8810581066 1999
`11 J Rubino and S Yalkowsky Cosolvency and cosolvent polarity
`Pharm Res 4220230 1987
`12 R E Coffman and D 0 Kildsig Hydrotropic solubilization
`mechanistic studies Pharm Res 1314601463
`1996
`13 B W Muller and E Albers Effect of hydrotropic substances
`on
`the complexation
`of sparingly soluble drugs with cyclodextrin
`derivatives and the influence of cyclodextrin complexation on the
`the drugs J Pharm Sci 80599604 1991
`of
`pharmacokinetics
`14 S C Lee G Acharya J Lee and K Park Hydrotropic poly
`mers Synthesis and characterization
`of polymers containing pi
`colylnicotinamide moieties Macromolecules 3622482255
`2003
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket